HE:AL: A Campus Dedicated To Health Technologies

The HE:AL’s launch date is scheduled for 2024 (Photo © Luxembourg Ministry of Economy)

Planned for 2024, the “Health And Lifescience Innovation Campus” will be based in Esch/Alzette. It will attract companies active in medical devices, in vitro diagnostics, and digital health tools and services.

Luxembourg economy minister Franz Fayot has announced the creation of a campus dedicated to health technologies in Esch-sur-Alzette.

The “Health And Lifescience Innovation Campus” (HE:AL Campus) “aims to attract primarily companies active in the field of medical devices, in vitro diagnostic devices, and digital health tools and services,” the ministry explained in a press release.

R&D, innovation and production activities, as well as consulting and services in the field of health technologies, are also targeted.

Financed by private investors, the infrastructure project will be based in Ehlerange, on a 2.4 hectare site not far from the House of BioHealth (HoBH), the future Südspidol of the Centre Hospitalier Emile Mayrisch (CHEM) and the Cité des Sciences de Belval.

Its location will promote “a geographical rapprochement between research, innovation and the medical world, key innovation partners in the health technology ecosystem,” adds the ministerial press release.

“By meeting the structural and infrastructure needs of companies in these sectors wishing to establish themselves in Luxembourg, the site will contribute to the development of technological pillars essential for the implementation of personalized medicine, centered on the use of health data, thanks to artificial intelligence.”

Its launch date is scheduled for 2024.

According to Luxinnovation, the Luxembourg health technology sector comprises 136 companies (about 1,900 people), 80% of which have fewer than 10 employees. Half of them are less than 10 years old.

“As a key element of the diversification strategy of the national economy, the health technology sector in Luxembourg is largely focused on the digitalisation of all aspects of health and the patient’s medical pathway with the objective of supporting the emergence of intelligent health products and services centered around personalized and digital medicine,” said Fayot.

Related Posts